Home / Companies / Jiangsu Weiqida Pharmaceutical Co., Ltd.

Jiangsu Weiqida Pharmaceutical Co., Ltd. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Jiangsu Weiqida Pharmaceutical Co., Ltd. has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Jiangsu Weiqida Pharmaceutical Co., Ltd." is on file.

What these totals cover: FDA records filed under the name "Jiangsu Weiqida Pharmaceutical Co., Ltd." and its spelling variant "Jiangsu Weiqida Pharmaceutical Co".

Latest inspection: Mar 21, 2025 · VAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	3	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Jiangsu Weiqida Pharmaceutical Co., Ltd.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	1	0	0	0	0
2024	0	0	0	0	0
2023	0	0	0	0	0
2022	0	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	0	0	0	0	0
2018	0	0	0	0	0
2017	1	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Jiangsu Weiqida Pharmaceutical Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Jiangsu Weiqida Pharmaceutical Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

3 inspections from Apr 30, 2014 to Mar 21, 2025.

Date	Site	Product	Classification	FEI
Mar 21, 2025	Nantong, China	Drugs	Voluntary Action Indicated (VAI)	3008245746
Dec 15, 2017	Nantong, China	Drugs	Voluntary Action Indicated (VAI)	3008245746
Apr 30, 2014	Nantong, China	Drugs	Voluntary Action Indicated (VAI)	3008245746

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3008245746	Nantong, China	3	Mar 21, 2025

Jiangsu Weiqida Pharmaceutical Co., Ltd. and the FDA: common questions

Has Jiangsu Weiqida Pharmaceutical Co., Ltd. received an FDA warning letter?

No FDA warning letter addressed to the name "Jiangsu Weiqida Pharmaceutical Co., Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Jiangsu Weiqida Pharmaceutical Co., Ltd. received an FDA Form 483?

FDA has not published a Form 483 for "Jiangsu Weiqida Pharmaceutical Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Jiangsu Weiqida Pharmaceutical Co., Ltd.?

The most recent FDA inspection on file ended Mar 21, 2025 at Nantong, China and was classified VAI. FDA has 3 inspections of Jiangsu Weiqida Pharmaceutical Co., Ltd. on file.

Need more than this page shows? Ask about Jiangsu Weiqida Pharmaceutical Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.